Skip to main content

Peer Review reports

From: Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2

Original Submission
5 Feb 2013 Submitted Original manuscript
19 Mar 2013 Reviewed Reviewer Report - Antimo Migliaccio
28 Mar 2013 Reviewed Reviewer Report - Lucia Anna Stivala
2 May 2013 Author responded Author comments - Hsien-Ming Wu
Resubmission - Version 2
2 May 2013 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
8 May 2013 Author responded Author comments - Hsien-Ming Wu
Resubmission - Version 8
8 May 2013 Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
20 May 2013 Reviewed Reviewer Report - Lucia Anna Stivala
24 May 2013 Reviewed Reviewer Report - Antimo Migliaccio
Resubmission - Version 10
Submitted Manuscript version 10
Publishing
31 May 2013 Editorially accepted
20 Jun 2013 Article published 10.1186/1471-2407-13-300

You can find further information about peer review here.

Back to article page